Personalized medicine--which uses genetic data to provide specialized medicine for individual patients--is slowly moving into the healthcare mainstream, though only a few practical applications exist to date. However, when it does become practical, it may be a financial blessing. A new report by the Deloitte Center for Health Solutions finds that personalized medicine could provide significant ROI for all of the key stakeholders in the U.S. healthcare system. Article